GLP-1 Prior Authorization Denied on Medicare? Here Is What to Do Next

You went to your doctor, discussed the Medicare GLP-1 Bridge program, met the eligibility criteria, and submitted a prior authorization — and it came back denied. This is frustrating, but it is not the end of the road. Prior authorization denials happen frequently in Medicare, and they can almost always be appealed. Many denials are caused by paperwork issues, missing documentation, or coding errors rather than genuine ineligibility. This guide walks you through exactly what to do next.

Why do GLP-1 prior authorizations get denied?

Understanding why your prior authorization was denied is the first step toward fixing it. The denial letter from your Part D plan should include a reason code or explanation. Here are the most common reasons for GLP-1 prior authorization denials under Medicare:

• Incomplete documentation — the most common reason. Your doctor's submission may have been missing required lab results, a BMI measurement, diagnosis codes, or documentation of qualifying health conditions.
• BMI below the threshold — your recorded BMI fell below 35 (or below 27 if you claimed a qualifying comorbidity), possibly due to an outdated measurement or a data entry error.
• Missing comorbidity documentation — if your BMI is between 27 and 34.9, you need documented evidence of at least one weight-related condition like pre-diabetes, cardiovascular disease, or sleep apnea. If this was not clearly documented, the authorization may be denied.
• Wrong diagnosis code — the prior authorization was submitted with a diabetes code rather than an obesity or weight management code, or vice versa, causing a mismatch with Bridge program requirements.
• Medication not on formulary — the specific medication or dose requested was not listed on your Part D plan's Bridge program formulary.
• Processing error — the submission went to the wrong processor, had incorrect patient identification, or was lost in the system.

Step 1: Read the denial letter carefully

Your Part D plan is required to send you a written explanation of the denial, called a Coverage Determination notice. This letter will include the specific reason for the denial, the medication that was requested, and instructions for how to appeal. Read it carefully and note the exact reason given. If the letter is confusing — and they often are — call the phone number on the letter and ask a plan representative to explain the denial in plain language.

Step 2: Contact your doctor's office

Call your prescribing physician's office and let them know the prior authorization was denied. Share the specific reason from the denial letter. In many cases, the doctor's office can resolve the issue by resubmitting with corrected or additional documentation. Common fixes include:

• Adding a current BMI measurement with date and method of measurement.
• Including recent lab results — A1C, fasting glucose, lipid panel, blood pressure readings.
• Adding ICD-10 diagnosis codes for qualifying comorbidities (hypertension, pre-diabetes, cardiovascular disease, obstructive sleep apnea, etc.).
• Writing a letter of medical necessity explaining why GLP-1 treatment is clinically appropriate for you specifically.
• Correcting coding errors — ensuring the submission uses the correct obesity/weight management diagnosis rather than a diabetes-only code.

Many denials are resolved at this stage without a formal appeal. A resubmission with complete documentation frequently results in approval within days.

Step 3: File a formal appeal if the resubmission is denied

If a corrected resubmission does not resolve the issue, you have the right to file a formal appeal. Medicare Part D has a structured, multi-level appeals process:

Level 1 — Redetermination by your Part D plan

You or your doctor submit a written request asking your Part D plan to reconsider the denial. The plan must respond within 7 calendar days for a standard request or 72 hours for an expedited request (if your doctor certifies that waiting could seriously harm your health). Include all supporting documentation — medical records, lab results, and your doctor's letter of medical necessity.

Level 2 — Independent Review Entity (IRE)

If Level 1 is denied, your case is automatically forwarded to an Independent Review Entity — a separate organization that reviews the denial with fresh eyes. The IRE is not affiliated with your Part D plan, which means you are getting an independent second opinion. The IRE must respond within 7 days for standard requests or 72 hours for expedited requests.

Level 3 and beyond

If the IRE also denies your request, additional appeal levels exist including a hearing before an Administrative Law Judge (if the amount in question exceeds a minimum threshold), review by the Medicare Appeals Council, and ultimately federal court review. Most cases are resolved at Level 1 or Level 2 — reaching Level 3 is uncommon for prescription drug prior authorizations.

How to request an expedited appeal

If your doctor believes that waiting for a standard appeal timeline could seriously harm your health, they can request an expedited (fast-track) appeal. This shortens the response deadline to 72 hours at each level. To request an expedited appeal, your doctor must provide a statement explaining why the delay could cause harm — for example, if you have uncontrolled blood sugar, worsening cardiovascular risk factors, or other conditions that would benefit from immediate GLP-1 treatment.

What documentation strengthens your appeal

The strongest appeals include comprehensive, well-organized documentation. If you are preparing for an appeal, make sure the following are included:

• A clear, current BMI calculation with date of measurement — ideally from within the past 30 days.
• Lab results confirming qualifying comorbidities — A1C for pre-diabetes, blood pressure readings for hypertension, sleep study results for sleep apnea, lipid panels for cardiovascular risk.
• A letter of medical necessity from your prescribing physician explaining why GLP-1 treatment is the appropriate intervention for your specific clinical situation.
• Documentation of previous weight management efforts — diet programs, exercise plans, behavioral counseling, or other interventions you have tried.
• A list of your current medications and how they relate to your weight-related health conditions.
• Any relevant imaging or specialist reports — for example, an echocardiogram or cardiac catheterization report if cardiovascular disease is the qualifying comorbidity.

How long does the appeal process take?

• Standard Level 1 (Redetermination): up to 7 calendar days.
• Expedited Level 1: up to 72 hours.
• Standard Level 2 (IRE): up to 7 calendar days after receiving the case.
• Expedited Level 2: up to 72 hours.
• Total typical timeline if resolved at Level 1: 1 to 2 weeks.
• Total typical timeline if resolved at Level 2: 2 to 4 weeks.

What if the appeal is approved?

If your appeal succeeds at any level, your Part D plan is required to authorize the medication. Your doctor can then send the prescription to a participating pharmacy, and you pick it up at the $50 Bridge program copay. The approval is typically valid for a set period — often 6 or 12 months — after which your doctor may need to submit a renewal prior authorization.

Getting help with your appeal

If the process feels overwhelming, you do not have to do it alone. Several free resources can help:

• Your State Health Insurance Assistance Program (SHIP) — every state has a SHIP that provides free, unbiased counseling on Medicare issues including appeals. Call 1-800-MEDICARE to find your local SHIP.
• Your doctor's office — many practices have dedicated staff who handle prior authorizations and appeals. Ask if they have a prior authorization coordinator.
• Medicare.gov — the official Medicare website has detailed information about the appeals process and your rights as a beneficiary.
• Patient advocacy organizations — groups focused on obesity and chronic weight management may offer guidance and support.

If you are tracking your health data on CairnSpace — daily meals, weight, symptoms, and check-ins — a printed summary of your tracking history can serve as additional supporting documentation in your appeal. It demonstrates your commitment to the treatment plan and provides your doctor with concrete data to reference in their letter of medical necessity.

Related Articles

• The Medicare GLP-1 Bridge Program: What It Is, Who Qualifies, and How to Enroll
• Does Medicare Cover GLP-1 Weight Loss Medications in 2026?
• How to Talk to Your Doctor About GLP-1 Medications on Medicare
• What Does a GLP-1 Medication Actually Cost on Medicare After July 2026?

Sources

• Centers for Medicare and Medicaid Services — Medicare Part D Appeals Process (medicare.gov)
• Medicare.gov — Your Right to Appeal a Coverage Decision
• CMS Medicare Managed Care Manual — Chapter 13: Grievances and Appeals
• State Health Insurance Assistance Program (SHIP) — ship.acl.gov
• Centers for Medicare and Medicaid Services — Medicare GLP-1 Bridge Program guidelines (2026)